The roles of BST‐2 in murine B cell development and on virus propagation
Microbiology and Immunology · 2023-03 · 67 (3) · 105-113
DOI: 10.1111/1348-0421.13049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology and Immunology, online erschienen am 27.01.2023. Verfasst von Shuzo Urata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan. Hauptthemen laut MEDLINE: Bone Marrow Stromal Antigen 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: A Joint Research Project grant from the Institute of Medical Science at the University of Tokyo.
Abstract (Originalsprache)
The bone marrow (BM) stromal cell antigen‐2 (BST‐2), also known as tetherin, CD317, PDCA‐1, or HM1.24, is a membrane protein overexpressed in several types of tumors and may act as a promising target for cancer treatment via antibody‐dependent cellular cytotoxicity. BST‐2 is also expressed in human BM stromal cells (BMSC), which support B cell development. While the activity of BST‐2 as an antiviral factor has been demonstrated, the expression patterns and the role of BST‐2 on B‐cell development and activation have not been investigated, especially in vivo . In this study, Bst2 knockout ( Bst2 −/− ) mice were generated to assess the role of BST‐2 on B cell development and activation. It was observed that BST‐2 was not expressed in BMSC or all B cell progenitors even in wild‐type mice and does not play a significant role in B cell development. In addition, the loss of BST‐2 had no effect on B cell activation. Furthermore and in contrast to the well‐known antiviral role of BST‐2, infection of vesicular stomatitis Indiana virus to the BM cells collected from the Bst2 −/− mice produced less infectious virus compared with that from the WT mice. These results suggest that murine BST‐2 is different from human BST‐2 in the expression pattern, physiological function, in vivo , and might possess positive role on VSV replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
- National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan.
- Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
- Pre-clinical Research Center, Tokyo Medical University, Tokyo, Japan.
- Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Saitama, Japan.
Förderung
- A Joint Research Project grant from the Institute of Medical Science at the University of Tokyo
Zitieren
APA
Urata, S., Yamaguchi, S., Nambu, A., Sudo, K., Nakae, S., & Yasuda, J. (2023). The roles of BST‐2 in murine B cell development and on virus propagation. Microbiology and Immunology, 67(3), 105-113. https://doi.org/10.1111/1348-0421.13049
Vancouver
Urata S, Yamaguchi S, Nambu A, Sudo K, Nakae S, Yasuda J. The roles of BST‐2 in murine B cell development and on virus propagation. Microbiology and Immunology. 2023;67(3):105-113. doi:10.1111/1348-0421.13049
BibTeX
@article{Urata2023,
author = {Urata, Shuzo and Yamaguchi, Sachiko and Nambu, Aya and Sudo, Katsuko and Nakae, Susumu and Yasuda, Jiro},
title = {The roles of BST‐2 in murine B cell development and on virus propagation},
journal = {Microbiology and Immunology},
year = {2023},
volume = {67},
number = {3},
pages = {105--113},
doi = {10.1111/1348-0421.13049}
}
EUVIMED